(via TheNewswire)
April 28, 2020 - TheNewswire - Tinkerine(TM) Studios Ltd. (TSXV:TTD) (OTC:TKSTF) ("Tinkerine" or the "Company") announces the receipt of approval from Health Canada for Covid-19 Medical Device Authorization for Importation or Sale of Class 1 Medical Devices. This approval is effective April 27,2020 and is valid for so long as the Interim Order respecting the importation and sale of medical devices for use in relation to Covid-19 is in effect.
The approval was granted to Tinkerine's wholly owned subsidiary, Tinkerine 3D Print Systems. Additional information on Health Canada approved Medical Devices can be viewed at:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/products-authorized-interim-orde.html#t1
About Tinkerine
Our mission is to provide a foundational understanding about Applied Design driven by 3D printing. Our ecosystem of 3D printing products and educational resources equips future generations with the innovative tools and products to stay ahead in a fast-paced, tech-driven world. Tinkerine enables the curious to convert creative ideas into the tangible and the unimaginable. All Tinkerine 3D printers and education services are designed and manufactured in Canada.
For further information please contact:
Dean Stuart
T: 403 617 7609
E: dean@boardmarker.net
Eugene Suyu
Chief Executive Officer